Cytotoxic Activity of Organotin(IV) Derivatives with Triazolopyrimidine Containing Exocyclic Oxygen Atoms

Autor: Rosalia Busà, Piera Sabatino, Alessandro Attanzio, Simone d'Agostino, Anna Frazzitta, Luisa Tesoriere, Simona Rubino, Maria Assunta Girasolo
Přispěvatelé: Alessandro Attanzio , Simone D’Agostino, Rosalia Busà, Anna Frazzitta, Simona Rubino, Maria Assunta Girasolo, Piera Sabatino *, Luisa Tesoriere, Attanzio A., D'Agostino S., Busa R., Frazzitta A., Rubino S., Girasolo M.A., Sabatino P., Tesoriere L.
Rok vydání: 2020
Předmět:
Denticity
Cell
Pharmaceutical Science
01 natural sciences
Analytical Chemistry
chemistry.chemical_compound
Drug Discovery
Organotin Compounds
triazolopyrimidine
Cytotoxicity
Membrane Potential
Mitochondrial

Cytotoxins
apoptosis
Biological activity
Hep G2 Cells
G2 Phase Cell Cycle Checkpoints
Gene Expression Regulation
Neoplastic

medicine.anatomical_structure
Chemistry (miscellaneous)
Mitochondrial Membranes
MCF-7 Cells
Molecular Medicine
Cyclin-Dependent Kinase Inhibitor p21
crystal structure
in vitro anticancer activity
Pyrimidine
Cell Survival
Stereochemistry
organotin(iv)
010402 general chemistry
Article
lcsh:QD241-441
Inhibitory Concentration 50
Structure-Activity Relationship
lcsh:Organic chemistry
medicine
Humans
Physical and Theoretical Chemistry
Metallodrug
010405 organic chemistry
Ligand
Organic Chemistry
Triazoles
HCT116 Cells
apoptosi
G1 Phase Cell Cycle Checkpoints
0104 chemical sciences
Pyrimidines
chemistry
metallodrugs
Cell culture
Apoptosis
Drug Design
Tumor Suppressor Protein p53
Reactive Oxygen Species
Zdroj: Molecules, Vol 25, Iss 4, p 859 (2020)
Molecules
Volume 25
Issue 4
ISSN: 1420-3049
Popis: In this study cytotoxicity of organotin(IV) compounds with 1,2,4-triazolo[1,5-a]pyrimidines, Me3Sn(5tpO) (1), n-Bu3Sn(5tpO) (2), Me3Sn(mtpO) (3), n-Bu3Sn(mtpO) (4), n-Bu3Sn(HtpO2) (5), Ph3Sn(HtpO2) (6) where 5HtpO = 4,5-dihydro-5-oxo-[1,2,4]triazolo-[1,5-a]pyrimidine, HmtpO = 4,7-dihydro-5-methyl-7-oxo-[1,2,4]triazolo-[1,5-a]pyrimidine, and H2tpO2 = 4,5,6,7-tetrahydro-5,7- dioxo-[1,2,4]triazolo-[1,5-a]-pyrimidine, was assessed on three different human tumor cell lines: HCT-116 (colorectal carcinoma), HepG2 (hepatocarcinoma) and MCF-7 (breast cancer). While 1 and 3 were inactive, compounds 2, 4, 5 and 6 inhibited the growth of the three tumor cell lines with IC50 values in the submicromolar range and showed high selectivity indexes towards the tumor cells (SI >
90). The mechanism of cell death triggered by the organotin(IV) derivatives, investigated on HCT-116 cells, was apoptotic, as evident from the externalization of phosphatidylserine to the cell surface, and occurred via the intrinsic pathway with fall of mitochondrial inner membrane potential and production of reactive oxygen species. While compound 6 arrested the cell progression in the G2/M cell cycle phase and increased p53 and p21 levels, compounds 2, 4 and 5 blocked cell duplication in the G1 phase without affecting the expression of either of the two tumor suppressor proteins. Compounds 1 and 2 were also investigated using single crystal X-ray diffraction and found to be, in both cases, coordination polymers forming 1 D chains based on metal-ligand interactions. Interestingly, for n-Bu3Sn(5tpO)(2) H-bonding interactions between 5tpO&minus
ligands belonging to adjacent chains were also detected that resemble the &ldquo
base-pairing&rdquo
assembly and could be responsible for the higher biological activity compared to compound 1. In addition, they are the first example of bidentate N(3), O coordination for the 5HtpO ligand on two adjacent metal atoms.
Databáze: OpenAIRE